Rexahn Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Rockville, Maryland, United States • 1-10 Employees

Rexahn Pharmaceuticals revenue & valuation

Annual revenue	$7,454,000
Revenue per employee	$1,065,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$23,900,000
Total funding	$8,600,000

Key Contact at Rexahn Pharmaceuticals

Deog Joong Kim

Senior Director

Company overview

Headquarters	15245 Shady Grove Rd, Suite 455, Rockville, MD 20850, US
Phone number	+12486819815
Websites	rexahn.com ocuphire.com
NAICS	3254
SIC	283
Keywords	Clinical Development, Pharmaceuticals, Oncology
Founded	2001
Employees	1-10
Socials

About Rexahn Pharmaceuticals

Rexahn Pharmaceuticals Inc. (NYSE American:RNN) is a clinical stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of cancer. The company's mission is to improve the lives of cancer patients by developing next-generation cancer therapies that are designed to maximize efficacy while minimizing the toxicity and side effects traditionally associated with cancer treatment. Rexahn's product candidates work by targeting and neutralizing specific proteins believed to be involved in the complex biological cascade that leads to cancer cell growth. Preclinical studies show that certain of Rexahn's product candidates may be effective against multiple types of cancer, including drug resistant cancers, and difficult-to-treat cancers, and others may augment the effectiveness of current FDA-approved cancer treatments. The company has two oncology product candidates, RX-3117 and RX-5902, in Phase 2 clinical development and additional compounds in preclinical development including RX-0201. For more information about the Company and its oncology programs, please visit www.rexahn.com.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Rexahn Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-02-23	14	$8,600,000

Funding Insights

$8,600,000

Total funding amount

$8,600,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Rexahn Pharmaceuticals is located in Rockville, Maryland, US.

You can reach Rexahn Pharmaceuticals at +12486819815.

Rexahn Pharmaceuticals generates an estimated annual revenue of $7,454,000. This revenue figure reflects the company's market position and business performance in its industry.

Rexahn Pharmaceuticals has an estimated valuation of $23,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Rexahn Pharmaceuticals was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.

Rexahn Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Rexahn Pharmaceuticals has raised a total of $8,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Rexahn Pharmaceuticals

Deog Joong Kim

Senior Director

4.8

40,000 users